Document is current
Any future updates will be listed below
-
Authors
Zhong, Xiaolin
Xiao, Hongyang
Lu, Weihong
Chen, Jiayuan
Chao, Fan
Tu, Ruiqin
-
Funding
Funding for this research was provided by:
Xiamen Municipal Healthcare Directed Project (3502Z20224ZD1074, 3502Z20224ZD1074, 3502Z20224ZD1074)
National Natural Science Foundation of China (82203743, 82203743)
Science Fund for Distinguished Young Scholars of Fujian Province (2023J05295, 2023J05295)
- License Information
-
More Information
Article History
Received: 25 November 2024
Accepted: 17 June 2025
First Online: 1 July 2025
Declarations
:
: Ovarian cancer pathological slides in the in-house dataset were obtained from Shanghai Zhuoli Biotechnology Company (Shanghai, China), with ethical approval from the Ethics Committee of Tongxu County People’s Hospital, Henan, China (approval number: ZL-XP201402). All patients provided written informed consent. External validation data were obtained from the TCGA public database, and all methods were performed in accordance with relevant guidelines and regulations.
: The authors declare no competing interests.
